- GlobeNewswire•12 hours ago
-Adds Two Rare Disease Medicines and Further Diversifies Company Revenue-. -Raises Full-Year 2016 Net Sales Guidance and Confirms Full-Year 2016 Adjusted EBITDA Guidance-. DUBLIN, Ireland, Oct. 25, 2016-- ...
- GlobeNewswire•19 days agoGainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Raptor Pharmaceutical Corp. (RPTP)
NEW YORK, Oct. 06, 2016-- Gainey McKenna & Egleston announces that a class action lawsuit has been filed against Raptor Pharmaceutical Corp. in the United States District Court for the District of Delaware ...
- Investor's Business Daily•25 days ago
The buzz around biotechs amped up a notch in the past week as Kite Pharma (KITE) and G.W. Pharmaceuticals (GWPH) socked away double-digit gains. Kite soared 10% in massive trade on Tuesday after announcing its KTE-C19 treatment showed a 47% complete remission rate in patients with the most common form of Non-Hodgkin lymphoma. The stock quickly backed off to end...
Raptor Pharmaceuticals Corp. (RPTP)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
|Day's Range||8.95 - 9.05|
|52wk Range||2.94 - 9.05|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-8.70|
|Avg Vol (3m)||2,362,710|
|Dividend & Yield||N/A (N/A)|